Clinical

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

Encouraging results with a shorter course of hepatitis C treatment were presented at the Digestive Disease Week meeting. Patients receiving an 8-week course of sofosbuvir and daclatasvir, previously naïve to direct-acting antiviral treatment, achieved a sustained response at 12 weeks.

Authors led by Harvard's Frank Hu, MD, write that combating diabetes worldwide requires policy solutions that recognize the societal and environmental forces that work against those who might try to pursue healthier lifestyles. Hu recently spoke at Patient-Centered Diabetes Care 2015, presented by The American Journal of Managed Care and Joslin Diabetes Center.

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

A study published in Nature Medicine highlights how genetic data can be translated in disease prevention and evidence-based clinical management.

Evidence-Based Diabetes Management invited the YMCA's Jonathan Lever, vice president for health strategy and innovation, to comment on his organization's involvement with the National Diabetes Prevention Program.

Researchers at Cancer Research UK have challenged the current standard of care in advanced ovarian cancer patients. Results of their study, published in Lancet, found that administering chemotherapy prior to surgery can have huge benefits on health outcomes and the patient's quality of life.

A secondary analysis on results of the CAPTION trial pointed to a role for pharmacists in helping tailor the treatment regimen for patients with hypertension, although it did not improve blood pressure control.

Until this study, no one had reported on how the discrepancies between adult and pediatric guidelines might affect treatment for young adults.

A Science study found that recurrent mutations in the promoter of the telomerase gene, TERT, could be responsible for overexpression of telomerase in a majority of cancers, thereby sustaining the replicative potential of cancer cells.

Two new insulins marketed by Sanofi offer improved options for patients: Toujeo is longer acting than its predecessor, Lantus. Afrezza, an inhaled insulin, is gaining praise from patients, if not from Wall Street.

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

Risk factors associated with diabetic ketoacidosis typically do not change. Preventing DKA should focus on identification of those most at risk and educating them good self-care to avoid incidents.

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

The editor in chief of Evidence-Based Diabetes Management welcomes those coming to the ADA Scientific Sessions to attend sessions featuring faculty from Joslin Diabetes Center.

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

Coverage from the 64th Scientific Sessions of the American College of Cardiology.

Findings of a study published in Infection Control & Hospital Epidemiology show that 95% of inpatients at a VA hospital in Minneapolis with an incorrect or indeterminate diagnosis, were given inappropriate antibiotics, as opposed to 38% who were accurately diagnosed, yet administered incorrect medication.

Data presented at the American Urological Association in New Orleans show a 50% drop in PSA testing in the years since the USPSTF issued its controversial D recommendation. Some see a "chilling" effect, but not all see a problem.

Large data sets like SEER need better quality control checks and researchers and clinicians who use these data sets should also consider using secondary data analyses that answer specific research questions. This is the advice of a senior urologist following the removal of the PSA data.

The findings in Diabetes Care served as early confirmation of what some had feared: a bifurcated Medicaid system will lead to an American of haves and have-nots in healthcare.

An evidence review supports a proposed USPSTF recommendation to update how the healthcare system screens for prediabetes.

Major professional and advocacy groups back legislation to create access to the National Diabetes Prevention Program.

With the right support, community providers can offer an effective approach to promoting population health and preventing chronic disease.